Advertisement

Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry

      Background

      Transesophageal echocardiography (TEE) is recommended in patients undergoing atrial fibrillation (AF) ablation, but use of this strategy is variable.

      Objective

      To evaluate whether TEE is necessary before AF ablation in patients treated with novel oral anticoagulants (NOACs).

      Methods

      We performed a prospective multicenter registry of AF patients undergoing radiofrequency catheter ablation on uninterrupted NOACs (apixaban and rivaroxaban). All patients were on NOACs for at least 4 weeks before ablation. Heparin bolus was administered to all patients before transseptal catheterization to maintain a target activated clotting time above 300 seconds. A subset of 86 patients underwent brain diffuse magnetic resonance imaging (dMRI) to detect silent cerebral ischemia (SCI).

      Results

      A total of 970 patients (514 [53%] apixaban patients and 456 [47%] rivaroxaban patients) were enrolled for this study. The mean age was 69.5 ± 9.0 years, with 824 patients (85%) having nonparoxysmal AF, and 636 patients (65.6%) were male. The average CHA2DS2-VASc score was 3.01 ± 1.3 and CHADS2 score was ≥2 in 609 patients (62.8%). Intracardiac echocardiogram ruled out left atrial appendage thrombus in all patients whose left atrial appendage was visualized (692, 71%), and detected “smoke” in 407 patients (42%). SCI at postprocedure dMRI was detected in 2.3% (2/86). One thromboembolic event (transient ischemic attack) (0.10%) with positive dMRI occurred in a patient on uninterrupted rivaroxaban with longstanding persistent AF.

      Conclusion

      Our study illustrates that performing AF ablation while on uninterrupted apixaban and rivaroxaban without TEE is feasible and safe. This finding has important clinical and economic relevance.

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • January C.T.
        • Wann L.S.
        • Alpert J.S.
        • et al.
        AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2014; 2014: e1-76
        • Calkins H.
        • Kuck K.H.
        • Cappato R.
        • et al.
        HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
        Heart Rhythm. 2012; 2012: 632-696
        • Briceno D.F.
        • Natale A.
        • Di Biase L.
        Heparin kinetics: the "holy grail" of periprocedural anticoagulation for ablation of atrial fibrillation.
        Pacing Clin Electrophysiol. 2015; 38: 1137-1141
        • Puwanant S.
        • Varr B.C.
        • Shrestha K.
        • Hussain S.K.
        • Tang W.H.
        • Gabriel R.S.
        • Wazni O.M.
        • Bhargava M.
        • Saliba W.I.
        • Thomas J.D.
        • Lindsay B.D.
        • Klein A.L.
        Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation.
        J Am Coll Cardiol. 2009; 54: 2032-2039
        • Scherr D.
        • Dalal D.
        • Chilukuri K.
        • Dong J.
        • Spragg D.
        • Henrikson C.A.
        • Nazarian S.
        • Cheng A.
        • Berger R.D.
        • Abraham T.P.
        • Calkins H.
        • Marine J.E.
        Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation.
        J Cardiovasc Electrophysiol. 2009; 20: 379-384
        • Calvo N.
        • Mont L.
        • Vidal B.
        • Nadal M.
        • Montserrat S.
        • Andreu D.
        • Tamborero D.
        • Pare C.
        • Azqueta M.
        • Berruezo A.
        • Brugada J.
        • Sitges M.
        Usefulness of transoesophageal echocardiography before circumferential pulmonary vein ablation in patients with atrial fibrillation: is it really mandatory?.
        Europace. 2011; 13: 486-491
        • McCready J.W.
        • Nunn L.
        • Lambiase P.D.
        • Ahsan S.Y.
        • Segal O.R.
        • Rowland E.
        • Lowe M.D.
        • Chow A.W.
        Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory?.
        Europace. 2010; 12: 927-932
        • Di Biase L.
        • Lakkireddy D.
        • Trivedi C.
        • et al.
        Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study.
        Heart Rhythm. 2015; 12: 1162-1168
        • Lakkireddy D.
        • Reddy Y.M.
        • Di Biase L.
        • et al.
        Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
        J Am Coll Cardiol. 2014; 63: 982-988
        • Ruisi C.P.
        • Brysiewicz N.
        • Asnes J.D.
        • Sugeng L.
        • Marieb M.
        • Clancy J.
        • Akar J.G.
        Use of intracardiac echocardiography during atrial fibrillation ablation.
        Pacing Clin Electrophysiol. 2013; 36: 781-788
        • Dello Russo A.
        • Fassini G.
        • Casella M.
        • et al.
        Usefulness of intracardiac echocardiography during pulmonary vein isolation with the novel multipolar irrigated ablation catheter (nMARQ).
        J Interv Card Electrophysiol. 2015; 44: 39-45
        • Di Biase L.
        • Elayi C.S.
        • Fahmy T.S.
        • et al.
        Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques.
        Circ Arrhythm Electrophysiol. 2009; 2: 113-119
        • Di Biase L.
        • Santangeli P.
        • Natale A.
        How to ablate long-standing persistent atrial fibrillation?.
        Curr Opin Cardiol. 2013; 28: 26-35
        • Di Biase L.
        • Gaita F.
        • Toso E.
        • et al.
        Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study.
        Heart Rhythm. 2014; 11: 791-798
        • Cappato R.
        • Marchlinski F.E.
        • Hohnloser S.H.
        • et al.
        Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
        Eur Heart J. 2015; 36: 1805-1811
        • Di Biase L.
        • Burkhardt J.D.
        • Santangeli P.
        • et al.
        Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
        Circulation. 2014; 129: 2638-2644
        • Cappato R.
        • Ezekowitz M.D.
        • Klein A.L.
        • et al.
        Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
        Eur Heart J. 2014; 35: 3346-3355
        • Klein A.L.
        • Murray R.D.
        • Grimm R.A.
        Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation.
        J Am Coll Cardiol. 2001; 37: 691-704
        • Koca V.
        • Bozat T.
        • Akkaya V.
        • Sarikamis C.
        • Turk T.
        • Vural H.
        • Ozdemir A.
        Left atrial thrombus detection with multiplane transesophageal echocardiography: an echocardiographic study with surgical verification.
        J Heart Valve Dis. 1999; 8: 63-66
        • Hilberath J.N.
        • Oakes D.A.
        • Shernan S.K.
        • Bulwer B.E.
        • D'Ambra M.N.
        • Eltzschig H.K.
        Safety of transesophageal echocardiography.
        J Am Soc Echocardiogr. 2010; 23: 1115-1127
        • Cappato R.
        • Calkins H.
        • Chen S.A.
        • Davies W.
        • Iesaka Y.
        • Kalman J.
        • Kim Y.H.
        • Klein G.
        • Packer D.
        • Skanes A.
        Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.
        Circulation. 2005; 111: 1100-1105
        • Gula L.J.
        • Massel D.
        • Redfearn D.P.
        • Krahn A.D.
        • Yee R.
        • Klein G.J.
        • Skanes A.C.
        Impact of routine transoesophageal echocardiography on safety, outcomes, and cost of pulmonary vein ablation: inferences drawn from a decision analysis model.
        Europace. 2010; 12: 1550-1557
        • Hutchinson M.D.
        • Jacobson J.T.
        • Michele J.J.
        • Silvestry F.E.
        • Callans D.J.
        A comparison of intracardiac and transesophageal echocardiography to detect left atrial appendage thrombus in a swine model.
        J Interv Card Electrophysiol. 2010; 27: 3-7
        • Reddy V.Y.
        • Neuzil P.
        • Ruskin J.N.
        Intracardiac echocardiographic imaging of the left atrial appendage.
        Heart Rhythm. 2005; 2: 1272-1273
        • Anter E.
        • Silverstein J.
        • Tschabrunn C.M.
        • Shvilkin A.
        • Haffajee C.I.
        • Zimetbaum P.J.
        • Buxton A.E.
        • Josephson M.E.
        • Gelfand E.
        • Manning W.J.
        Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages.
        Heart Rhythm. 2014; 11: 1890-1897
        • Lin D.
        • Callans D.J.
        Use of intracardiac echocardiography during atrial fibrillation ablation to avoid complications.
        Future Cardiol. 2015; 11: 683-687